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Characterization, Simulation and Control
of a Soft Helical Pneumatic Implantable Robot for Tissue Regeneration
Eduardo Perez-Guagnelli1†, Joanna Jones1†, Ahmet H. Tokel1, Nicolas Herzig1,
Bryn Jones1, Shuhei Miyashita1 and Dana D. Damian1
Abstract— Therapies for tissue repair and regeneration have
remained sub-optimal, with limited approaches investigated
to improve their effectiveness, dynamic and control response.
We introduce a Soft Pneumatic Helically-Interlayered Actuator
(SoPHIA) for tissue repair and regeneration of tubular tissues.
The actuator features shape configurability in two and three
dimensions for minimal or non-invasive in vivo implantation;
multi-modal therapy to apply mechanical stimulation axially
and radially, in accordance to the anatomy of tubular tissues;
and anti-buckling structural strength. We present a model and
characteristics of this soft actuator. SoPHIA reaches up to
36.3% of elongation with respect to its initial height and up to
7 N of force when pressurized at 38 kPa against anatomically-
realistic spatial constraints. Furthermore, we introduce the
capabilities of a physical in vivo simulator of biological tissue
stiffness and growth, for the evaluation of the soft actuator in
physiologically-relevant conditions. Lastly, we propose a model-
based multi-stage control of the axial elongation of the actuator
according to the tissue’s physiological response. SoPHIA has the
potential to reduce the invasiveness of surgical interventions
and increase the effectiveness in growing tissue due to its
mechanically compliant, configurable and multi-modal design.
I. INTRODUCTION
The impact of soft robots has been seen throughout the
medical field, e.g., in assistive technologies and rehabilita-
tion [1], minimally invasive surgery [2], implants [3], and
wearables [4]. One of the main advantages of soft robots is
their compliance, enabling safe interaction with the human
body and thus, increasing the wearability of technologies for
the treatment of various clinical conditions.
Tissue repair, in particular, can benefit from the character-
istics of soft robots, such as gentle dexterous handling, pal-
pation, anatomical and functional support. Advanced surgical
tools, e.g., Da Vinci robots, have demonstrated the benefit of
added accuracy and minimizing invasiveness to the surgical
procedures for tissue repair. However, they require surgeon
supervision during the surgery, but provide no further control
of the tissue repair beyond the surgical intervention. Al-
ternatively, tissue engineering aims to restore the structure
and function of a tissue by stimulating cells to proliferate
on scaffolds using chemical growth factors [5]. Despite
advances in structural tissue regeneration, tissue engineering
faces challenges such as lack of vascularity in new tissue,
poor mechanical compatibility, and lack of control of the
regeneration process after the scaffold implantation [6].
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Fig. 1. The soft helical actuator for mechanostimulation-based tissue regen-
eration. (a) The envisaged implantation of SoPHIA inside the esophagus to
treat the long-gap condition. It may be attached to the tissue by using sutures
or adaptors [7]. (b) A view of the helical actuator made by configuring two
actuation chambers. (c) The two chambers, axial (AAC) and radial (RAC)
before the helical configuration to stimulate the tissue axially and radially
respectively [8].
Mechanotherapy has been found to have assistive and
therapeutic effects for a variety of medical conditions [9], in-
cluding tactile sensory restoration [10], wound healing [11],
regeneration of skeletal muscle and esophageal tissue [12],
bone growth and skin grafts [13], [14].
Robotic implants are a new medical technology with the
potential to unify the advantages of mechanical stimulation to
tissue repair and regeneration, by exploiting the cells’ intrin-
sic proliferation mechanisms. They also have the potential to
engineer and control the process of tissue repair, brought by
medical devices, robots and surgical assistance, during the
entire duration of treatment via remote communication [15].
These regenerative implants may be deployed inside the body
and be mounted on the target tissue. There, they will exert
controlled and gentle forces, and elongation on the tissue to
induce regeneration and healing.
An example of potential therapies in which robotic im-
plants may be of use is the regeneration of the gastrointestinal
(GI) tract. This type of regeneration is required for conditions
such as long-gap esophageal atresia (LGEA) (Fig. 1 (a)) or
short bowel syndrome (SBS), congenital conditions in which
more than two-thirds of these organs may be missing [16],
and for which current treatments prove suboptimal with high
mortality rates [17]. Our group recently introduced a robotic
implant that was able to induce growth of esophageal tissue
using mechanostimulation and showed 77% of tissue growth
over nine days [12]. This rigid implant was mounted on the
esophagus and gently pulled the tissue axially. It was able to
apply traction forces in the range of 1-2.5 N and displaced
up to 5 cm of tissue [3].
Despite the potential of these robotic implants, the in vivo
studies also revealed a range of unanticipated challenges due
to the fixed design of the implant operating long-term in a
harsh in vivo environment. Given the interaction between
the rigid implant and the tissue, we ascertained that tissue
scar level was significant, 37% of the new tissue, because of
collagen formation.
The derived requirements for mechanostimulation-based
robotic implants for tissue regeneration are: (1) mechanical
compliance to reduce inflammation [18]; (2) minimally in-
vasive implantation by surgeons in various parts of the GI
tract; (3) a design that allows hyperelastic linear deformation
while securing anti-buckling structural strength to resist
considerable loading; (4) safe control of the delivery of
mechanical stimulation.
To address these requirements, we introduced the concept
and fabrication of a Soft Pneumatic Helically-Interlayered
Actuator (SoPHIA). This multi-modal soft actuator is com-
posed of two pneumatic chambers coiling together into
a tubular implant for mechanotherapy tissue regeneration
(Fig. 1 (b-c)) [8]. Due to its helical arrangement and re-
inforced walls, the soft helical actuator is capable of both
axial elongation and radial expansion to stimulate the growth
and function of the longitudinal and circular muscles of the
GI tract. In this work, we present a holistic characterization
of the soft actuator’s capabilities in the axial, radial, and
combined actuation mode, a simulation using a novel in vivo
tissue growth simulator, as well as the control of SoPHIA.
II. RELATED WORK AND DESIGN REQUIREMENTS
The clinical requirements mentioned in the previous sec-
tions translate into a number of technical requirements. First,
the actuator should be soft to mechanically comply with
the target tissue. Recent studies in material engineering
and tissue regeneration suggest that mechanically compliant
implants [18] and the application of mechanotherapy may
reduce the inflammatory response of the body [19]. Soft-
matter robotic implants would thus be a suitable choice for
mechanotherapy-based tissue repair.
Second, the actuator should be modular, to facilitate
implantation, and configurable, to allow its mounting on
tubular tissues in a non-invasive or minimally invasive man-
ner. Soft actuator research has generally focused on pre-
programmed axial lengthening and bending actuation based
on fluidic control, for navigation in surgical applications or
for exoskeletons [20]. Advances have been made towards
modular soft robots for assistive applications [21]. Such
devices are highly desirable for non-invasive surgery and im-
plantation as well, yet have not been tested for their reliable
extension under sustained loading conditions, as required for
mechanostimulation. More recent work has also explored the
strength of these actuators with programmable composites,
demonstrating the exertion of axial forces to lift up to 1kg
after being pressurized at 23.8 kPa, and the expansion of
more than 200% their original size [22]. However, the
actuator has a large volume due to its origami creases, which
is not desirable for an implant that seemingly coats a tubular
tissue. While soft medical devices and implants have been
recently proposed [23], more work needs to be done to
reduce the implantation invasiveness.
Third, the actuator should elongate with the growing tissue
without buckling due to load from the tissue or the body’s
spatial constraints. As soft actuators’ directional expansion
needs to be increased, to support large tissue reconstruction,
it is critical to have actuators that maintain structural strength
and do not buckle under load. The compliance of soft robots
is limiting in this regard, making it challenging for them to
withstand forces from their environments [24].
Helical or coiled structures are widely found, in both
biology and engineering, due to their ability to handle tension
and compression [25], or to provide enhanced maneuverabil-
ity and stability, for example to endoscopic instruments [26].
When used in soft robotic systems, they also provide in-
creased dexterity, more efficient workspaces by using routed
tendons [27], enhanced area of contact and stability when
acting as a gripper [28]. Nevertheless, scarce attention has
been put into their investigation.
Fourth, a control of the actuator similar to the current clin-
ical treatment is needed. In general, it is difficult to develop
accurate models and control of soft actuators [29] due to the
diversity in hyperelastic-based material constituents. Recent
research has developed a variety of new methods for control,
capable of dealing with the increased dimensionality and
complexity [30]. One common approach for bending linear
soft robots is derived from piecewise constant curvature
modeling, based on which classical control strategies can
be employed [31]. Despite the promising results, for more
complex soft robots, the method is often ill-suited, as the
dynamic behavior with the environment is not captured.
Apart from these typical problems, overcoming the soft actu-
ator’s reliable extension under loading adds new challenges,
such as buckling and undesirable bending. Given the gap in
control strategies for complex soft robots, we used one of
the common approaches of outsourcing some of the control
to the robot’s morphology and design [32].
In this paper, we embed the aforementioned requirements
in a helically configurable soft pneumatic actuator that ap-
plies controlled multi-modal mechanostimulation. We intro-
duce the following contributions to this area of research: (1)
introduction of the concept of coiling soft assembly for real-
izing deployable, multi-modal, compact, soft yet strong, and
adaptable soft robotic implants; (2) modeling and mechanical
characterization of a soft helical actuator for axial elongation
and radial expansion to deliver mechanostimulation to tissue;
(3) a physical in vivo simulator of the biological tissue’s
stiffness and growth to allow for the evaluation of the
helical actuator’s performance; (4) a model-based multi-
stage control of the axial elongation of the helical actuator
according to tissue’s physiological response.
Fig. 2. SoPHIA Design. (a) Pneumatic chambers with embedded polyester
that constraints inflation. (b) The pneumatic chambers can be configured
into a helix around structures of varying diameter. (c) Cross-sectional area
of SoPHIA when the RAC is inflated. (d) Cross-sectional area of SoPHIA
when the AAC is inflated. (e) Cross-sectional area of SoPHIA when both
chambers are inflated.
III. SOPHIA’S CONCEPTUAL DESIGN
We designed a soft actuator that is based on the anatomy of
the GI tract. Most of the GI tract presents two types of muscle
layers with fibers oriented circularly and longitudinally [33].
Therefore, a soft actuator for these organs should apply
traction forces to both ends of the muscle layers in order
to optimize the quality of the engineered tissue.
SoPHIA is an entirely soft actuator, made out of two
identical elastomeric pneumatic chambers; the axial actu-
ation chamber (AAC) and the radial actuation chamber
(RAC) (Fig. 2 (a)). Each chamber has a length of 48 cm,
reaching 10.7 cm of height when the chambers are helically
arranged and unpressurized. SoPHIA has a total weight of
95 grams. The chambers are made of Ecoflex 00-30 (Smooth-
on Inc.) and can be configured into a helix of different
diameters, depending on the tubular organ where it is placed
(Fig. 2 (b)). They are wrapped in polyester fabric, which
in the AAC restricts radial expansion, while in the RAC
restricts axial elongation (Fig. 2 (c-e)). The AAC expands
to displace adjacent chambers, increasing the axial size of
SoPHIA. The RAC exhibits laterally emerging balloons from
the unconstrained sections, yielding radial expansion. These
chambers are coiled together into a helical structure with
interlayered actuation (Fig. 2 (e)) (Fig. 1 (b-c)). Details of the
conceptual design, fabrication and Finite Element Modeling
of the chambers are in [8]. Details on SoPHIA’s fixation to
ex vivo esophagus tissue are described in [7].
IV. SOPHIA’S ANALYTICAL MODEL
In this section, an analytical model of the helical actu-
ator is introduced and validated, to understand the relation
between the physical components and their mechanical re-
sponse to pressurization.
A. Analytical model
For simplicity, the model is separated into two parts, one
model for the AAC and one for the RAC. The main perfor-
mance metrics are elongation and expansion. At equilibrium,
the force balance equations projected respectively on ex and
er (Fig. 3) can be written as:






wσerRdθ = 0 (2)
where Fex denotes the resistance force of the elastomeric
walls to expansion along ex, Ft is the resistive force of the
host tissue during the mechanotherapy treatment, Px and Pr
are the relative pressure of the air inside the air channels of
the AAC and the RAC respectively. Sx is the cross-sectional
area of the air channel of the AAC, h denotes the height of
the air channel of the RAC, w is the thickness of the RAC
walls and R is the external radius of the RAC, σer is the
elastic stress of the elongated wall in the radial expansion
of the robot, θ1 and θ2 are the angular limits of the area
considered for the force balance equation, and finally dθ is
the angular differential for the integration.
Fig. 3. Model of the simplified (a) side-view and (b) top-view axial elon-
gation showing the interacting forces and areas respectively. (c) Perspective
cross-sectional area and (d) top-view radial expansion showing the lengths
and interacting forces respectively.
We made the assumption that the two chambers can be
decoupled and act independently in a single direction and
that they deform uniformly. To simplify the analysis, we
assumed that the coiled chambers behave as a stack of N
circular chambers. The weight of the actuator and the weight
of the air are neglected. Finally, we neglect any possible
radial force applied by the tissue to the robot in order to
match the characterization test presented in section V.
Fig. 4. Experimental validation of the mathematical model for SoPHIA’s actuation chambers. (a) Side view of three AAC pressurized SoPHIA coils used
to validate the mathematical model of axial inflation. (b) Experimental and analytical evaluation of the AAC actuation. (c) Top view of one of the RAC
pressurized SoPHIA coils used to validate the mathematical model of radial inflation. (d) Experimental and analytical evaluation of the RAC actuation.
Error bars stand for standard deviation of 3 trials. We pressurized the samples from 0 to 25 kPa for the AAC and from 0 to 22 kPa for the RAC. For the
AAC, we used 2 N of load to represent the resistive force of the host tissue [12]. For the RAC, the resistive force was not considered.
Silicone rubbers are known as hyperelastic materials.
Using a Neo-Hookean model for incompressible material in
a uniaxial elongation to describe the elastic behavior of the




























Ax is the cross-sectional area of the elongated material in
the AAC, E is the Young’s modulus of the material, L is the
height of the AAC after elongation, L0 is the initial height
of the AAC, w is the width of the elongated material in the
RAC, R, Ri, and R0 are respectively the external radius of
the RAC once elongated, the internal radius of the RAC, and
the initial external radius of the RAC. Fig. 3 illustrates the
main parameters considered in the model.
The model parameters are given in Table. I. In order
to estimate the Young’s Modulus, we used least squares
curve fitting using the axial elongation results with the
model obtained in equation (3). The Young’s modulus was
optimised in the range of values found in the literature,
from E = 0.027 MPa [34] to E = 0.069 MPa [35]. After
the fitting, the best Young’s modulus was determined to be
E = 0.068 MPa. The values in Table. I are based on the
geometry of the actuator. The value for the resistance force
Ft was taken from [12].
B. Experimental validation of the model
Two experiments were run to validate the analytical model
derived in the previous section. To validate the analytical
model for the AAC, we coiled three turns of that chamber
around an oiled (Cole Parmer VacuumPump Oil CP 500)
PLA tube to reduce friction and support it vertically without
restricting its movement (Fig. 4 (a)). An ABS plate at the
top of the AAC acted as a reference for the two reflective
distance sensors (GP2Y0A41SK0F, Sharp) to measure the
elongation, as well as to support the weights that simulate the
TABLE I
MODEL PARAMETERS
Notation Description Value Unit
Sx cross-sectional area of the inner
channel of the AAC
415 mm2
Ax cross-sectional area of the
elongated material in the AAC
829 mm2
w width of the elongated material
RAC
6 mm
h height of the RAC air channel 3 mm
R0 initial external radius of the RAC 2.49 mm
Ri internal radius of the RAC 17.5 mm
L0 initial height of the AAC 9 mm




resistive force Ft. We used two distance sensors, averaging
the readings, in order to avoid inaccuracies due to uneven
elongation of the actuator on either side. We pressurized the
AAC from 0 to 25 kPa and recorded the elongation readings
to obtain L. We performed three trials. For the experiments,
we define elongation as L−Lo
L
.
To validate the RAC, we glued one turn of the RAC,
along its entirely constrained face, around an ABS tube
using cyanoacrylate adhesive (Fig. 4 (c)). The ABS tube was
supported by a clamp stand. Then, we pressurized the RAC
from 0 to 20 kPa and measured its radial expansion, defined
as R−Ro
R
over three trials using ImageJ (NIH).
For both chambers, relative pressure was considered. The
maximum pressure values were defined considering pressur-
ization before anisotropic deformation and failure.
As can be seen in Fig. 4 (b) and Fig. 4 (d), there is a
reasonable agreement between the theoretical models and the
experimental values. The Root Mean Square Error (RMSE)
between the three AAC elongation trials and the analytical
model are 2.5%, 2.9%, and 3.6%. This means that on
average, the error taken by using the model instead of the
real data is 3.0 percentage points of elongation. The RMSE
between the three RAC elongation trials and the model are
3.0%, 2.1%, and 3.2%; in this case the average error is
2.8 percentage points of expansion. The RMSE over trials
shows that the error made per trial is consistent. The average
error is similar for the two chambers but their ranges of
expansion are different. Since the AAC has a longer stroke,
the normalized standard error is smaller than for the RAC.
The observed differences, in both the AAC and the RAC,
can be explained by the model limitations. First, the proposed
model only takes into account the wall elongation in one
direction during the pressurization, but does not consider
the ballooning behavior of the chambers. Secondly, the
Neo-Hookean model was chosen for its simplicity, in order
to provide information about the impact of each design
parameters, e.g., size, Young’s modulus, on the actuator’s
elongation for a potential adaptation of SoPHIA to other
applications.
V. SOPHIA CHARACTERIZATION
We conducted experiments to characterize SoPHIA’s elon-
gation, expansion and force capabilities, to determine both
its standalone capabilities, as well as those under conditions
that are expected clinically. This section describes the cor-
responding experimental setups and methods. The electronic
control platform is described in [8].
A. Axial Elongation
Considering that SoPHIA’s primary application is to elon-
gate tissue via mechanostimulation, it is relevant to charac-
terize its axial elongation in dynamic conditions in order
to evaluate its suitability to elongate tissue. In this set
of experiments, we investigated the hysteresis of SoPHIA
by measuring the free-load axial elongation response of
the AAC, the RAC and the simultaneous pressurization
(AAC+RAC) to pressures of 25 kPa, 20 kPa and a combined
55 kPa respectively. These were pressurization cycles of
2 seconds.
Fig. 5. Experimental setups to characterize elongation, expansion and
force capabilities. (a) SoPHIA placed around an oiled tube and a rod that
guides the axial freeload elongation of an ABS plate to record the actuator’s
elongation. (b) Two force sensors were placed at the top and bottom of an
axially restricted SoPHIA to measure axial forces. (c) Three force sensors
were placed on the expandable sections of the RAC to record forces exerted
against a PET sheet that envelops SoPHIA. (d) SoPHIA restricted axially
and radially to record overall forces.
We placed SoPHIA around an oiled (Cole Parmer Vacuum
Pump Oil CP 500) plastic tube to reduce friction and support
it vertically without restricting its movement. A rod guided
the axial elongation of an ABS plate that worked as a refer-
ence to the distance sensors to measure SoPHIA’s elongation
(Fig. 5 (a)). This rod was necessary for the benchtop tests,
yet not needed for the clinical setting when SoPHIA will
be fixed to the tubular tissue. We performed three trials of
five cycles each. Then, we inflated the AAC+RAC up to
their breakage point to find their maximum expansion before
failure, leaving time to settle. For this experiment, we only
needed the oiled tube to support the actuator under free-load
conditions (Fig. 5 (a)). The elongation was recorded and then
measured using ImageJ (NIH).
B. Axial and Radial Output Forces
Given that SoPHIA may be used as an implantable device,
it is necessary to understand the potential forces that it can
exert against the target tissue. According to [12], forces
to stretch the tissue axially should be around 2.3 N. In
order to investigate if this force requirement is fulfilled,
and considering the interdependence of the AAC and the
RAC found in our previous work [8], we proceeded to
characterize the force interactions between the two chambers
under constrained and unconstrained setups, performing five
trials for each set of conditions.
To measure the axial forces exerted by SoPHIA’s elon-
gation, we placed two force sensors on the top and bottom
of the actuator respectively, and we restricted its expansion
in these same two locations as shown in Fig. 5 (b). Both
force sensors were averaged to get an overall reading of the
maximum axially exerted force. Then, we pressurized the
AAC and the RAC independently and simultaneously. The
constraints were placed in direct contact with SoPHIA. To
measure the radial forces exerted by SoPHIA’s expansion, the
actuator was enveloped in a rigid polyethylene terephthalate
(PET) cylinder with force sensors adhered to its inner surface
and in direct contact with the unconstrained segments in
the RAC, as shown in Fig. 5 (c). Then, we pressurized the
AAC and the RAC independently and then simultaneously.
To measure the overall forces that SoPHIA can exert, the
actuator was constrained both axially and radially at the same
time (Fig. 5 (d)). Then we pressurized the AAC and the RAC
independently and then simultaneously.
C. Structural Strength
Since SoPHIA needs to sustain forces over a long period
of time, structural strength is an important feature to test,
to determine how much weight the implant can support,
at different inflation levels, without buckling. To test the
structural strength, both the axial and radial chambers were
inflated at 3 different levels of averaged pressure - 10.5 kPa,
13.5 kPa and 16.5 kPa - as well as non-inflated. With no
constraints around SoPHIA, weights were then progressively
added, until we observed the actuator buckling. The weights
were guided on to the top cap of SoPHIA by an acrylic tube.
We repeated the experiment five times.
Fig. 6. SoPHIA’s dynamic elongation behavior. (a) Elongation behavior
as a function of axial pressure and (b) as a function of radial pressure
when the AAC and the RAC are simultaneously actuated. SoPHIA exhibits
hysteresis behavior and yields up to 30% of freeload axial elongation under
pressurization cycles of 2 seconds. Experimental conditions are detailed in
Section V-A.
Fig. 7. SoPHIA’s static behavior under different actuation modes. (a)
SoPHIA in a relaxed state, (b) with only the RAC inflated, (c) only the
AAC chamber inflated and (d) both chambers inflated. By inflating the
AAC (25 kPa) and the RAC (20 kPa) simultaneously, SoPHIA is capable
of reaching 36.3% of elongation in comparison to its original size.
VI. RESULTS
A. Axial Elongation
Under dynamic conditions, with two-second cycles,
SoPHIA can axially elongate 0.25 cm at 25 kPa when
only the AAC is pressurized, 0.7 cm at 20 kPa when only
the RAC is inflated and 2.8 cm when both are pressur-
ized simultaneously (Fig. 6). The elongation capability is
enhanced by simultaneous pressurization of the chambers,
exhibiting nonlinear and hysteresis behavior. In comparison,
under static conditions (when the actuator had time to settle)
SoPHIA can axially elongate 3.2%, 17.7% and 36.3% of its
original size when the RAC, the AAC and RAC+AAC are
actuated respectively (Fig. 7).
B. Axial and Radial Output Forces
SoPHIA is capable of exerting up to 7 N axially, when
the AAC and the RAC are pressurized simultaneously at
38 kPa while entirely constrained (Fig. 8 (c)), and it only
exerts 0.69 N radially under the same conditions (Fig. 8 (d)).
This behavior is constant along all the setups, meaning that
SoPHIA tends to direct its forces 90% more axially than
radially. This is confirmed by looking at Fig. 8 (a) and
(b). This result is positive considering the intended clinical
application as it means that SoPHIA is capable of exerting
higher forces than the ones needed in proved functional
mechanotherapy [12] at low levels of pressure. SoPHIA can
exert up to 1.35 N of force at 38 kPa when it is radially
constrained which is equivalent to the force we would be
able to yield against a tubular organ (Fig. 8 (b)).
C. Structural Strength
SoPHIA’s helical configuration provides increasing struc-
tural strength, with increasing levels of average pressure. In
a relaxed state, SoPHIA can stand 500 g of weight without
buckling (Fig. 9 (a)). This strength increases as the actuator
increases its inner pressure. Pressurized at an average of
16.5 kPa, it can withstand up to 800 g (Fig. 9 (b)).
VII. SOPHIA STAGED CONTROL
After characterizing SoPHIA, the control requirements for
the real-life application were considered. Envisaging the in
vivo tissue growth treatment, SoPHIA will be fixed at its
ends inside the tubular organ and will inflate axially every
24 hours in order to apply tension to the tissue. During
the week-long traction procedure, the physiological response
of the tissue stiffening is to resist to the applied traction
forces [16]. A release of this tension can be observed on the
tissue between the traction applications, as a consequence of
tissue relaxation and growth. In this section, we describe the
setup, experimental procedure, results and SoPHIA’s control
used to simulate staged tissue growth mechanotherapy.
A. Tissue Growth Simulation
1) Physical Simulator: A benchtop tissue growth simu-
lator, shown in Fig. 10, was developed in order to derive
the control of SoPHIA in an environment similar to the one
in vivo. The benchtop simulator has two roles: to simulate
the tissue stiffness and growth, and to monitor SoPHIA’s
performance. The tissue growth and stiffness are simulated
via two mechanisms: a passive spring actuated plate, and a
controlled lifting plate. Monitoring is then achieved using
pressure, force and distance recordings from the platform.
Tissue growth and stiffness were simulated using a combi-
nation of passive and active mechanisms. The tissue stiffness
is replicated using a compression spring (LP 026LM 06S316,
Lee Springs) - which has a 0.05 N/mm spring rate, 50.8 mm
free length, 7.035 mm solid length. As SoPHIA lengthens it
experiences a resistant force corresponding to the level of
spring compression. The spring itself was mounted around a
plastic rod capped by two acrylic plates to prevent buckling.
The tissue growth was achieved using the active mecha-
nism, made up of two NEMA-23 stepper motors (57STH56,
Phidgets), controlled by two stepper motor drivers (TB6600,
TopDirect) through an Arduino Uno R3 microcontroller. The
two motors are coupled to two vertical M8 threaded bars
which lift the moving plate. The moving plate itself carries
the passive spring mechanism and, when displaced vertically,
allows the spring to decompress, thus simulating tissue
growth. The tissue growth is monitored via two distance
sensors which measure the displacement of the moving plate.
Throughout the simulation, SoPHIA is also monitored by
three different sensor readings: pressure, force and distance.
The pressure recordings are taken from the dedicated AAC
and RAC PCBs. Similarly to the previous experiments, the
Fig. 8. Mean output force capabilities with standard deviation for five trials. (a) Axial forces under axial constraints and three actuation modes. (b) Radial
forces under radial constraints and three actuation modes. (c) Axial forces under axial+radial constraints and three actuation modes. (d) Radial forces under
axial+radial constraints and three actuation modes. As expressed in the results section, axial forces represent the most benefited from interdependence
between chambers with the lowest standard deviation among trials and conditions. Experimental conditions are specified in Section V-B.
Fig. 9. SoPHIA’s structural strength demonstrated (a) in a relaxed state and
(b) at an averaged pressure of 16.5 kPa withstanding a maximum weight of
800 g.
Fig. 10. Physical simulator of tissue stiffness and growth. (a) Overall side
view; (b) detail of the sensors and actuator in the physical simulator.
force recordings are taken from four force sensors, two
placed on the top and two placed on the bottom. SoPHIA’s
elongation is measured by taking the average of two distance
sensors which track the displacement between the spring
actuated plate and the ground plate.
2) Experimental Procedure: We simulated the growth of
3.2 cm of virtual tissue by expanding SoPHIA axially, inflat-
ing simultaneously the AAC and the RAC. The elongation
of both chambers was semi-constrained by the spring actu-
ated plate, in order to simulate the resistance that SoPHIA
will experience from the tissue under stretch. SoPHIA was
constrained by a PET sheet, simulating its enclosure in a
tubular tissue shown in Fig. 11 (a). Both chambers were
pressurized simultaneously, controlled by the target distance
determined for each stage, shown in Fig. 11 (a-e). The overall
target distance of 3.2 cm was chosen as the maximal semi-
constrained inflation elongation before risk of failure.
The procedure followed for the simulation of tissue growth
consists of four stages described in Fig. 11. Firstly the
actuator is inflated and then the moving plate is lifted to
decompress the spring mechanism. Using this procedure, two
sets of experiments were performed. The first set consisted
of using manually tuned values for each stage that were
then further improved in the second set using modeling and
automatic tuning. Each set of experiments consisted of five
trials. In this setup, SoPHIA exerts up to 0.19 N of force
before decreasing as a result of the upwards displacement of
the moving plate, simulating tissue relaxation at the end of
each stage (Fig. 12). These results match with the previously
stated experimental protocol in Fig. 11 (a-e). The initial
interaction force between SoPHIA and the tissue simulator
was set to around 0 N, although could be tuned to other
values depending on the initial position of the moving plate
relative to SoPHIA.
Fig. 11. Experimental procedure for the simulation of tissue growth
treatment based on the staged application of traction forces. The dashed
yellow lines represent the initial and final states of the moving plate. (a)
SoPHIA in a relaxed state; (b) end of stage 1 reaching 0.8 cm, (c) end
of stage 2 reaching 1.6 cm, (d) end of stage 3 reaching 2.4 cm, and (e)
end of stage 4 reaching 3.2 cm. (f) Flowchart describing each stage in the
simulation.
Fig. 12. Force response of SoPHIA caused by its elongation. The decrease
in force represents the end of each of the stages during the simulation.
B. Modeling and Control for Axial Elongation
In this section, the control details of SoPHIA’s axial
elongation in the tissue growth simulator are explained. The
requirements of the controller are first established and more
details about the controller used are given. The modeling ap-
proach is then presented, detailing how the transfer function
models are derived. Finally, the control tuning is described
and compared against the initial requirements.
1) Specifications: To establish the requirements for the
controller design, both the clinical requirements and the
current limitations of the actuator were taken into account.
A steady-state error requirement of less than 1mm was set.
The steady-state error was limited to 1 mm, to be as small
as possible, while taking into account the precision of the
distance sensors that is around ±1 mm. In addition, the rise
time was set to be maximized to ensure a slow elongation
of the tissue and to avoid tearing.
For the system itself, a position PI controller was used,
as it was deemed appropriate to meet the requirements. A
target elongation of 0.8 cm for each stage was chosen, to
have 4 stages of visually noticeable elongation. Additionally,
an overall safe pressure limit of 39 kPa was enforced, and
stopped inflation if reached, to ensure SoPHIA would not
burst. This overall safe pressure limit was determined from
the maximum pressure of the previous experiments. Based
on these design requirements and inspired by the current
daily clinical intervention for tissue elongation [16], a gain-
scheduled lengthening process was hypothesized to be suit-
able. Gain-scheduling was chosen to allow for better tracking
of the reference signal and improve the overall behavior
of the actuator. The PI values for all of the stages were
initially set based on testing of previous actuators, before
being improved later based on the modeling.
2) Modeling: For each of the stages, a model was found
using system identification to aid with the tuning of the PI
controller. Based on the linear dynamics observed in each
stage, a low order linear time invariant transfer function
was fit to the data. Of the five trials conducted, the best
trial, selected based on minimal overshoots and minimal
steady-state error for each stage, was chosen for modeling.
A model was fit to this selected trial, identifying a second
order model for stage 1 and first order models for the
remaining stages. The transfer functions were determined
Fig. 13. Plot of all of the trials with the improved control throughout all
4 stages.
using subspace identification with an automatic estimation
of the initial condition and using the instrument variable
approach for initialization.
3) Control: The PI values for each of the stages were
tuned to meet the requirements set out in section VII-B.1.
The overall aim of the tuning process was to achieve a
smaller steady-state error, while keeping rise time as slow
as possible. The digital tuning of the PI values was done
using the Ziegler-Nichols method applied to the developed
model transfer functions. For the tuning, a small steady-
state error was prioritized, as well as a slow rise time to
achieve a steady inflation. After this initial digital tuning,
the PI values were then further fine-tuned, taking into ac-
count the noticed behavior changes to smooth the response.
Fig. 13 shows the comparison between initial and improved
control throughout all 4 stages, where we demonstrate an
improvement by implementing automatic tuning on the gain-
scheduled lengthening process control scheme. The averaged
achieved performance from the first five trials and the next
five trials with improved control are summarized in Table. II.
Overall, most of the stages showed a decrease in steady-
state error or at least comparable values with the improved
control, although this did come at the cost of greater
overshoots and faster rise times. Additionally, compared to
the initial tunings, where rise times were not available for
stages 1 and 4 as 90% of the target value was not reached,
all of the stages with the improved control reached these
target values as a minimum. Overall, the system met the
requirement of a steady-state error of less than 1 mm across
all stages, promising safe operation for the envisaged clinical
procedure.
VIII. DISCUSSION & CONCLUSION
We introduced a Soft Pneumatic Helically-Interlayered
Actuator (SoPHIA), capable of configurability and multi-
modal axial elongation and radial expansion, that we envis-
age as an implantable device to provide mechanostimulation
for tissue growth. We evaluated SoPHIA’s performance using
a novel physical simulation platform that we envisage to be
used as a research tool for tissue regeneration simulation.
We tested the capability of this actuator by evaluating
the elongation, output force and characterizing its nonlinear
behavior. SoPHIA is capable of growing axially 36.3% its
TABLE II
AVERAGED PERFORMANCE CHARACTERISTICS FOR THE INITIAL AND
IMPROVED TRIALS. TR: RISE TIME, OS: OVERSHOOT AND SSE:
STEADY-STATE ERROR.
Initial Final
Stg1 Stg2 Stg3 Stg4 Stg1 Stg2 Stg3 Stg4
Tr (s) x 4.05 3.30 x 1.12 1.20 1.90 2.45
OS (%) 0 0.25 1.50 0.44 11.25 4.63 2.83 5.94
SSE (cm) 0.11 0.05 0.04 0.09 0.07 0.02 0.05 0.07
original size under freeload static conditions at an average
pressure of 22.5 kPa and 33.3% under loaded-staged control
at an average pressure of 21 kPa. By constraining SoPHIA
entirely and then pressurizing both chambers, which is a
clinically-realistic condition, SoPHIA can exert up to 7 N
axially and up to 1.35 N radially, if only the RAC is pressur-
ized. These capabilities make the actuator suitable to address
the reconstruction of tissues in clinical conditions such as
LGEA (where more than 3 cm of tissue is missing) or SBS.
While the output performance of the soft actuator is
comparable to many soft pneumatic actuators [36], [21], the
design and behavior of SoPHIA provide unique features that
are clinically advantageous:
• By using a geometrically simple building block (actua-
tion chambers) that can be coiled from one to a three-
dimensions actuator, we can configure SoPHIA into a
cylinder that fits to various diameters of hollow organs
and tubular tissues, making it a versatile medical tool.
• Its ease of configuration could facilitate clinical inter-
vention on different organs. This potentially could be
done by performing a small incision near the target
organ, through which the AAC and RAC could be
inserted, implanted and removed employing minimally
invasive surgery procedures such as laparoscopy.
• By varying the orientation of the chambers, we can ad-
dress different conditions. For example, the RAC could
be oriented to expand inwards in order to stimulate the
intestine during SBS treatment. It can also be oriented
to expand outwards during LGEA treatment (Fig. 1).
• The helical shape also provides structural support, with
air pressure distributed uniformly across the diameter
and height of the actuator. We showed that the implant
can support up to 800 g without buckling. This feature
is clinically important as buckling could lead to a
misshaped organ.
Over the duration of the treatment, the AAC may be pro-
gressively inflated to support the lengthened tissue. The RAC
may be intermittently inflated to provide radial stimulation
to the tubular organ and also decrease fibrotic response.
Powering and monitoring a robotic implant via loose cabling
that exits the body through a skin port into a control box
was demonstrated clinically viable in [12]. For the pneumatic
tubing a similar approach is envisaged, however this needs
to be tested pre-clinically. As presented in our previous
work [7], adaptors can be used to attach SoPHIA without
being in direct contact with the organ to heal, in order
to reduce fibrosis. SoPHIA’s helical configuration provides
multi-modal behavior achieved by interlayering elastomeric
chambers of different functions into the helix. Typically, soft
helical actuators show some degree of torsion when they
incorporate a backbone into their design [37]. SoPHIA is
a zero-torsion helical actuator due to it being constrained
axially and radially.
From the dynamic elongation tests, we observed that the
RAC generates much more elongation than the AAC, whilst
under static conditions the opposite is true. We hypothesize
that this difference comes from the AAC having a much
slower response time, partly caused by the stacking of coils.
As the RAC showed superior dynamic expansion than the
AAC, which is desirable for mechanotherapy, one option is
to use the RAC design for axial inflation as well. Another al-
ternative to increase SoPHIA’s axial elongation is to decrease
shear stress between the chambers caused by their different
expansion rates that currently causes the actuator to burst.
We evaluated the behavior of SoPHIA using a novel
physical simulator. During a week-long clinical tissue length-
ening treatment, the tissue may become stiffer (due to
inflammation), relax (due to its viscoelastic properties) or
grow. These mechanical and physiological changes are being
emulated by the physical simulator. Such simulations are
difficult to achieve with current phantom tissues or with
ex vivo biological tissues, as they exhibit limited length-
ening. This makes the physical tissue growth simulator
ideal to dynamically represent different states of tissues,
from mechanical to metabolic, under either physiological or
pathological conditions. Further work still needs to be done
to simulate the radial growth, as well as the real-time stiffness
variation of the tissue.
While the soft-matter actuator is desirable for its stretcha-
bility to support a growing tissue, its intrinsic nonlinear be-
havior needs to be precisely controlled for clinical safety. We
thus developed a staged-position gain-scheduled controller,
which emulates the daily tissue stretch within the existing
clinical treatment. We successfully evaluated the implant
control in a physiologically-relevant scenario. Variability of
the system represents an important challenge when control-
ling it due to the sensor disturbances and elastomer non-
linearity and wear. However, the presented analytical model
constitutes a reliable tool for the prediction of the AAC
and the RAC behavior, as there is a reasonable agreement
between the theoretical models and the experimental values
(Fig. 4 (b) and Fig. 4 (d)). Although the proposed model
does not consider the ballooning behavior of the chambers, it
provides qualitative information of the design parameters that
impact SoPHIA’s elongation. In the future other nonlinear
models, such as Ogden, will be investigated in order to
provide more detailed performance insights.
Due to the lack of kinematic equations that describe soft
robots in general [31], our approach was a combination of
using traditional control techniques and designing constraints
to achieve the desired actuation. However, further research is
still needed in order to model the behavior of soft machines
from first principles. Consequently, we may be able to tune
the controller better to decrease the steady-state error, while
keeping large rise times. Force control could also be used,
such that SoPHIA applies constant traction forces and adapts
to the tissue response.
Future directions include embedding soft sensors to record
SoPHIA’s elongation and forces, in order to carry out more
accurate mechanotherapy control in vivo. Further work also
includes the advancement of the axial elongation capability
of SoPHIA for a larger capacity of tissue lengthening.
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